CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023

21 يونيو 2023 06:59:39 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 يونيو 2023 06:30:09 بحسب Nasdaq GlobeNewswire

Crinetics to Highlight Broad Pipeline at ENDO 2023

09 يونيو 2023 06:30:08 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 مايو 2023 15:21:55 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

04 مايو 2023 15:05:12 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 أبريل 2023 15:31:01 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 مارس 2023 15:37:50 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

28 فبراير 2023 15:05:39 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 فبراير 2023 16:21:42 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

10 فبراير 2023 07:01:33 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 يناير 2023 15:48:48 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

09 يناير 2023 07:01:39 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 ديسمبر 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Provides Update on CRN04777 Program

28 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference

22 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

14 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 نوفمبر 2022 15:30:43 بحسب Nasdaq GlobeNewswire

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly

13 أكتوبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 أكتوبر 2022 15:57:25 بحسب Nasdaq GlobeNewswire

Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism

06 أكتوبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire